Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Medical treatments for benign prostatic hyperplasia mainly relieve symptoms, while surgery is more effective but not always suitable for elderly patients.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

The dog's fertility was restored with antibiotics and finasteride treatment.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Finasteride can cause enlarged breasts.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Testosterone therapy increases bone density in older men with low testosterone levels.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Finasteride didn't significantly improve ICPPS symptoms, more research needed.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Tamoxifen effectively treats gynecomastia without causing impotence.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.